TRT and bodybuilding coaching claims: what the evidence says

What did @coach.agz actually say?

The creator walked through trestolone acetate (MENT) as a synthetic 19-nor androgen, calling it "super testosterone" and describing it as "stronger than testosterone milligram for milligram." He flagged aggressive aromatization into 7-alpha-methyl estradiol, prolactin risk from its 19-nor structure, and warned that "estrogen and prolactin are not controlled, MENT will turn on you very fucking fast." He also described MENT as a "surgical tool, not a lifestyle compound" and listed rapid muscle accrual, extreme pumps, and high libido as expected effects. He then offered a PDF on MENT use to anyone who commented the word "MENT."

To his credit, this was not a use-it-and-get-jacked pitch. He repeatedly flagged risks. But he was still framing an unapproved, non-prescribed research compound as something with a manageable risk profile if you just track biomarkers, which deserves serious scrutiny.

Does the science back this up?

Mostly, yes, with some gaps. MENT's pharmacology is legitimately unusual, and the core claims here are reasonably grounded in published research, though much of that research is decades old and in small samples.

The "stronger milligram for milligram" claim checks out directionally. Sundaram et al. (1998, Journal of Andrology) established that MENT has roughly 10 times the myotropic potency of testosterone in animal models. Its androgen receptor binding affinity is significantly higher than testosterone, which is consistent with what the creator described. The claim that MENT "does not require 5-alpha reduction" is accurate and pharmacologically important. Unlike testosterone, MENT is already active at the androgen receptor without conversion by 5-alpha reductase, which means it does not produce DHT, a point the creator skipped but that matters for prostate and scalp risk profiles.

The aromatization claim is accurate. MENT converts to 7-alpha-methyl estradiol, which is more potent than estradiol at the estrogen receptor. Kumar et al. (1992, Steroids) documented this conversion pathway. The prolactin claim for 19-nor compounds is pharmacologically plausible and consistent with what is observed clinically with nandrolone, though MENT-specific prolactin data in humans is thin.

What did they get wrong (or right)?

The SHBG claim is where things get fuzzy. The creator said MENT "suppresses your SHBG hard, which ultimately just means more free testosterone." This is mechanistically sloppy. SHBG suppression from androgens does increase free testosterone fraction, but MENT itself is the active compound in this context, not a testosterone adjunct. The framing implies MENT is useful for boosting free testosterone as a secondary benefit, which conflates its mechanism with that of compounds like danazol or stanozolol used specifically for SHBG suppression. The effect exists but the clinical relevance is overstated here.

The "CNS, libido, and strength signaling" language is vague and not well-defined in any published MENT literature. This reads as experiential gym knowledge, not clinical pharmacology.

What he got right: the risk warnings are legitimate. Water retention, blood pressure elevation, estrogen-driven mood changes, and prolactin-driven libido crashes are real and documented concerns with this compound class. His insistence on frequent blood work and conservative dosing is the correct public-health framing, even if it implies MENT is a manageable self-directed option, which it is not legally or medically.

What should you actually know?

MENT is not approved by the FDA for any indication. It was studied as a male contraceptive and potential androgen replacement candidate in small trials, but it never progressed to clinical use. There is no standardized dose, no approved formulation, and no regulatory oversight of products sold under this name. Anyone obtaining MENT is getting a research chemical or an unregulated product, and purity and concentration cannot be verified.

The creator's risk warnings are real but incomplete. He does not mention cardiovascular strain beyond blood pressure, does not address erythrocytosis risk, and does not note that "frequent blood work" alone does not make an unmonitored supraphysiologic androgen protocol safe. Monitoring biomarkers catches problems after they start, not before.

If you are experiencing symptoms of hypogonadism, low testosterone, or hormonal dysregulation, the correct path is evaluation by a licensed clinician, not a compound with no approved clinical use and a PDF from a TikTok coaching account.

The bottom line on this video

This is one of the more pharmacologically literate TikTok breakdowns of MENT you will find, and the risk warnings are not performative. But the structure of the video, ending with a lead magnet PDF for people who comment "MENT," is a coaching funnel built on engagement with a compound that has no legal, prescribed, or approved use pathway. The science he cited is real. The product he is pointing people toward is not regulated. Those two things can both be true at the same time.